Avid Bioservices Inc (CDMO)

[pphmtoolong]

Only two months to completed enrollment in the Sunrise Phase III trial. Must have 500 patients under treatment worldwide, 250 or so with Bavi in their veins.

SK told us they expect the first look-in triggered by 33% of the trial patients evented in the first half of 2016. For the patients sake I hope we don't see the first look-in for a while. If the wait extends past March, and if the share price continues at these low levels, it will be very tempting to add to my already substantial share count.

We'll see.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul